Oscar Health (OSCR) Price & Analysis

Compare

1,936 Followers

OSCR Stock Chart & Stats

Day’s Range― - ―

52-Week Range$11.20 - $23.79

Previous CloseN/A

Volume1.52M

Average Volume (3M)23.80M

Market Cap

$4.24B

Enterprise Value$5.78B

Total Cash (Recent Filing)$2.99B

Total Debt (Recent Filing)$299.75M

Price to Earnings (P/E)49.6

Beta0.93

Next Earnings

Nov 11, 2025

EPS Estimate

-0.55

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.89

Shares Outstanding219,163,000

10 Day Avg. Volume17,459,662

30 Day Avg. Volume23,795,977

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap1.36

Enterprise Value/Revenue0.57

Enterprise Value/Gross Profit0.57

Enterprise Value/Ebitda29.19

Forecast

1Y Price Target

$10.67

Price Target Upside-35.95% Downside

Rating ConsensusModerate Sell

Number of Analyst Covering8

Bulls Say, Bears Say

Bulls Say

Cash Flow PerformanceCash Flow CFO was $509MM, +2.4% y/y and well above the estimate of $135MM.

Cost ManagementOSCR plans to eliminate $60mn of admin costs in 2026, which should drive ~50bp of margin.

Revenue GrowthOSCR raised revenue guidance to $12.0-$12.2B.

Bears Say

Market RiskMarket risk scores are significantly higher than previously assumed, contributing to a cautious outlook.

Membership DeclineExpectations of disenrollment ranging from 20-50% of exchange membership will create a radically different risk pool.

Profitability ConcernsThe pricing strategy for Oscar Health, Inc. does not appear adequate to produce stable margins in the current year.

Oscar Health News

ACA Rule Pause Offers Relief to UnitedHealth (UNH) and Peers Facing Rising Costs

UnitedHealth Group ($UNH) and other major health insurers breathed a sigh of relief. A federal judge in Maryland...

9d ago

CNC

Mixed options sentiment in Oscar Health with shares down 1.53%

Mixed options sentiment in Oscar Health (OSCR), with shares down 26c near $16.39. Options volume roughly in line...

14d ago

OSCR

Moderately bullish activity in Oscar Health with shares up 6.44%

Moderately bullish activity in Oscar Health (OSCR), with shares up 94c, or 6.44%, near $15.62. Options volume roughly...

18d ago

OSCR

Oscar Health price target lowered to $13 from $14 at Piper Sandler

Piper Sandler analyst Jessica Tassan lowered the firm’s price target on Oscar Health (OSCR) to $13 from $14...

20d ago

OSCR

Moderately bullish activity in Oscar Health with shares up 1.3%

Moderately bullish activity in Oscar Health (OSCR), with shares up 20c, or 1.3%, near $15.18. Options volume relatively...

21d ago

OSCR

Mixed options sentiment in Oscar Health with shares up 5.75%

Mixed options sentiment in Oscar Health (OSCR), with shares up 82c, or 5.75%, near $15.16. Options volume relatively...

26d ago

OSCR

Oscar Health reports Q2 EPS (89c), consensus (84c)

Reports Q2 revenue $2.86B, consensus $2.92B. “We believe the individual market has long-term upside and is the future...

28d ago

OSCR

Oscar Health reaffirms FY25 revenue view $12.0B-$12.2B, consensus $12.01B

06:24 EDT Oscar Health (OSCR) reaffirms FY25 revenue view $12.0B-$12.2B, consensus $12.01B Published first on TheFly – the...

28d ago

OSCR

Option traders moderately bearish in Oscar Health with shares down 0.98%

Option traders moderately bearish in Oscar Health (OSCR), with shares down 14c near $13.71. Options volume relatively light...

28d ago

OSCR

Sell Rating for Oscar Health Amid Uncertainties in Guidance and Margin Improvement

In a report released today, Stephen Baxter from Wells Fargo reiterated a Sell rating on Oscar Health, with...

21d ago

OSCR

Oscar Health’s Earnings Call: Growth Amid Challenges

Oscar Health, Inc. (($OSCR)) has held its Q2 earnings call. Read on for the main highlights of the...

26d ago

OSCR

Cautious Outlook: Oscar Health’s Financial Challenges and Sell Recommendation Amid Industry Uncertainties

Oscar Health, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Joanna Gajuk from...

27d ago

OSCR

Oscar Health Reports Q2 2025 Revenue Growth Amid Losses

Oscar Health, Inc. ( ($OSCR) ) has released its Q2 earnings. Here is a breakdown of the information...

27d ago

OSCR

Mixed options sentiment in Oscar Health with shares down 3.92%

Mixed options sentiment in Oscar Health (OSCR), with shares down 57c near $14.10. Options volume relatively light with...

1M ago

OSCR

OSCR FAQ

What was Oscar Health’s price range in the past 12 months?

Oscar Health lowest stock price was $11.20 and its highest was $23.79 in the past 12 months.

What is Oscar Health’s market cap?

Oscar Health’s market cap is $4.24B.

When is Oscar Health’s upcoming earnings report date?

Oscar Health’s upcoming earnings report date is Nov 11, 2025 which is in 69 days.

How were Oscar Health’s earnings last quarter?

Oscar Health released its earnings results on Aug 06, 2025. The company reported -$0.89 earnings per share for the quarter, missing the consensus estimate of -$0.809 by -$0.081.

Is Oscar Health overvalued?

According to Wall Street analysts Oscar Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Oscar Health pay dividends?

Oscar Health does not currently pay dividends.

What is Oscar Health’s EPS estimate?

Oscar Health’s EPS estimate is -0.55.

How many shares outstanding does Oscar Health have?

Oscar Health has 219,163,000 shares outstanding.

What happened to Oscar Health’s price movement after its last earnings report?

Oscar Health reported an EPS of -$0.89 in its last earnings report, missing expectations of -$0.809. Following the earnings report the stock price went up 3.763%.

Which hedge fund is a major shareholder of Oscar Health?

Currently, no hedge funds are holding shares in OSCR

Oscar Health Stock Smart Score

Underperform

Fundamentals

Return on Equity

-14.04%

Trailing 12-Months

Asset Growth

29.94%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Oscar Health

Oscar Health, Inc. (OSCR) is a technology-driven health insurance company focused on leveraging data and technology to enhance member experience and improve health outcomes. The company provides individual and family health insurance plans, small group insurance, and Medicare Advantage plans across the United States. Oscar Health differentiates itself through its consumer-oriented approach, telehealth services, and seamless digital platform that offers personalized care and support to its members.

Oscar Health (OSCR) Earnings & Revenues

Historic Earnings Reports

OSCR Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

Oscar Health's earnings call highlighted significant revenue growth and strategic acquisitions, yet faced challenges with increased MLR, operational losses, and higher risk adjustment payables. The company's efforts to improve SG&A efficiency and expand through strategic partnerships are positive steps, but financial losses and market challenges weigh heavily.View all OSCR earnings summaries

OSCR Stock 12 Month Forecast

Average Price Target

$10.67

▼(-35.95% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","14":"$14","21":"$21","10.5":"$10.5","17.5":"$17.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$13.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,10.5,14,17.5,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.58,13.535384615384615,13.490769230769232,13.446153846153846,13.401538461538461,13.356923076923078,13.312307692307693,13.267692307692307,13.223076923076922,13.178461538461539,13.133846153846154,13.089230769230769,13.044615384615385,{"y":13,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.58,13.356153846153846,13.132307692307693,12.908461538461538,12.684615384615384,12.46076923076923,12.236923076923077,12.013076923076923,11.78923076923077,11.565384615384616,11.341538461538462,11.117692307692307,10.893846153846154,{"y":10.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.58,13.150769230769232,12.721538461538461,12.292307692307693,11.863076923076923,11.433846153846154,11.004615384615384,10.575384615384616,10.146153846153846,9.716923076923077,9.287692307692307,8.858461538461539,8.42923076923077,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.06,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.3,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.63,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.65,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.43,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.44,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.6,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.61,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.97,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.26,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.58,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >